[ad_1]
British pharmaceutical company AstraZeneca joined the line of companies that announced the results of its anti-Coronavirus vaccine, which it is developing jointly with the University of Oxford.
In a statement released Monday, AstraZeneca said the Covid-19 vaccine is 70 percent effective in preventing the disease.
This is less convincing than the Pfizer / Biontech and Our Directors vaccines, which are close to 95 percent effective, and also lower than the percentage announced by Russia for its “Sputnik 5” vaccine, which it said is up to 92 percent. .
However, the company clarified that these are temporary results, and was based on clinical trials that were conducted on a large scale in both Britain and Brazil, and included 20,000 people, including 131 people who contracted the disease.
But what sets the AstraZeneca vaccine apart is that it uses more traditional technology than the two competing vaccines, making it less expensive and easier to store as it does not need to be stored at a low temperature.
It should be noted that the Pfizer / Biontec vaccine should be stored at a temperature as low as minus 70 degrees Celsius, while the Moderina vaccine can be stored at temperatures suitable for normal refrigerators, that is, between 2 and 8 degrees.
The company considers in the statement that its vaccine is “highly effective” in preventing the disease, especially since no participant in the trials had any serious type of disease and no one was taken to hospital, according to AFP.
Preliminary results relate to trials involving more than 20,000 people, including 131 who were infected with the disease.
In detail, the effectiveness of the vaccine increases in a first group of people who received half a dose, then a full dose after a month, and the effectiveness decreases to 62 percent in another group that received two doses a month apart, according to reported AFP.
The drug group does not provide further details to explain this difference in effectiveness.
In all, the third phase of large-scale clinical trials involves 60,000 people worldwide and has also been conducted in the United States, Japan, Russia, South Africa, Kenya, and Latin America.
The British company indicates that it will promptly present these results to the authorities with a view to obtaining initial approval.
The statement quoted Astraseneca CEO Pascal Sorio as saying that thanks to a “simple supply chain”, the vaccine “will be available and available in all parts of the world,” according to AFP.
The group says it is making rapid progress in manufacturing the three billion doses that will be available in 2021.
British Health Minister Matt Hancock told Sky News he was “very happy” with this “encouraging” news.
He added: “It is important that the independent regulatory body (in Britain), the regulatory agency for medicines and health care products, looks at the data and verifies that (the vaccine) is effective and safe,” noting that ” this vaccine that was developed in Great Britain is easier to store than the Fayez vaccine because it does not need to be kept at a temperature of minus 70 degrees Celsius. “
The price of the AstraZeneca vaccine is expected to be cheaper than the prices of the two competing vaccines, as the price of the Pfizer vaccine is estimated at about $ 40, while the price of the Moderna vaccine is estimated at about $ 27 .
"); //}, 3000);}}); //$(window).bind('scroll '); $ (window) .scroll (function () {if (alreadyLoaded_facebookConnect == false) {alreadyLoaded_facebookConnect = true ; // $ (window) .unbind ('scroll'); // console.log ("scroll loaded"); (function (d, s, id) {var js, fjs = d.getElementsByTagName (s)[0]; if (d.getElementById (id)) return; js = d.createElement (s); js.id = id; js.async = true; js._https = true; js.src = "https://connect.facebook.net/en_US/all.js#xfbml=1&appId=148379388602322"; fjs.parentNode.insertBefore (js, fjs); } (document, 'script', 'facebook-jssdk')); // pre_loader (); // $ (window) .unbind ('mousemove'); // setTimeout (function () {// $ ('# boxTwitter'). html ("Tweets from @tayyar_org"); //}, 3000); var scriptTag = document.createElement (" script "); scriptTag.type =" text / javascript "scriptTag.src =" https://news.google.com/scripts/social. js "; scriptTag.async = true; document.getElementsByTagName (" head ")[0].appendChild (scriptTag); (function () {$ .getScript ("https://news.google.com/scripts/social.js", function () {});}); }}); //$(window).load(function () {// setTimeout (function () {// // add the returned content to a newly created script tag // var se = document.createElement ('script'); / / se.type = "text / javascript"; // //se.async = true; // se.text = "setTimeout (function () {pre_loader ();}, 5000);"; // document. getElementsByTagName ('body')[0].appendChild (se); //}, 5000); //});
[ad_2]
